Macugen Articles
Valeant bags another company, Eyetech
14 February 2012
Merck & Co gets EU approval for Victrelis; Pfizer withdraws Macugen indication extension
20 July 2011
Four Novartis drugs and B-MS
9 March 2009
Pfizer's 3rd-qtr 2008 profit triples due to Exubera write-off; revenues flat at $12B
27 October 2008
Novartis will pay towards Lucentis in UK
1 September 2008
UK's NICE to finalize approval of Lucentis
7 April 2008
Elderly urged to change lifestyle to battle AMD
3 March 2008
Alcon's Retaane gets FDA approvable letter
1 October 2007
NICE wet AMD drug rethink after 13,000 complaints
13 August 2007
UK's NICE "fails common sense test"
25 June 2007
Macugen use safe for three years
27 November 2006
Germany spends 3.28B euros on wet AMD
25 September 2006
Pfizer's Macugen cleared in Scotland
14 August 2006
Stock Commentary - New York week to July 3, 2006
10 July 2006
OSI's Macugen sees strong data at ARVO 2006
15 May 2006
Pfizer advises label changes on Macugen
17 April 2006
OSI Pharma sees 2005 losses fall to $157.1M
20 March 2006
Pfizer/OSI's Macugen gets OK in Europe
27 February 2006
EC approves Pfizer's Macugen for wet AMD
13 February 2006
Eyetech sees new indication for Macugen
23 May 2005
Health Canada clears Eyetech/Pfizer's Macugen
23 May 2005
Eyetech affirms Macugen's safety profile
16 May 2005
Eyetech: mouse data confirms Macugen's mechanism
16 May 2005
Eyetech learns Medicare reimbursement terms
14 February 2005
First launch for Eyetech/Pfizer's Macugen in USA
31 January 2005
Isis to shares Macugen royalties for $24 M
10 January 2005
Eyetech due $90M as FDA clears Macugen
10 January 2005
Macugen an effective therapy for AMD
10 January 2005
Eyetech buys new facility
22 November 2004
EyeTech sees 3rd-qtr net loss widen
1 November 2004
Macugen NDA accepted by FDA
23 August 2004
Gilead sees sales jump 30% for 2nd-qtr
9 August 2004
Eyetech sees losses grow on Macugen development costs
2 August 2004
Isis earns $1M milestone on Macugen filing
28 June 2004
Eyetech/Pfizer file NDA for Macugen
28 June 2004
Eyetech's Macugen to be reviewed in August
31 May 2004
Pfizer to build up ophthalmology business in Japan
1 March 2004
Showing 1-52 of 52 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
